Health Condition 1: Z940- Kidney transplant status Health Condition 2: null- Renal transplant acute rejection
Conditions
Interventions
None listed
Sponsors
Sanofi Synthelabo India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient >= 18 years of age 2. Patient is a candidate for renal transplant 3. The investigator decides to use Thymoglobuline as induction therapy independent of this registry 4. signed informed consent Note-Renal transplant could be a first transplant or a repeat transplant
Exclusion criteria
Exclusion criteria: 1. Active, acute or chronic infections 2. Hypersensitivity to rabbit proteins or any of the excipients 3. Pregnancy or lactation 4. Concurrent participation (or participation in the previous 12 weeks) in any another clinical trial 5.Any contraindication to use of Thymoglobuline 6. Special transplants such as combined kidney and other organ like pancreas transplants, ABO incompatible transplants, and transplant requiring desensitization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute rejection (as diagnosed by the Investigator as per his normal clinical practice Including both clinically suspected and biopsy proven rejection) during the period of 12 months in patients treated with Thymoglobuline for immunosuppression for renal transplant 2. Graft survival at the end of 6 months and 1 year 3. Infections (including CMV infections) over a period 12 months Renal function using Glomerular Filtration Rate (GFR) assessed by MDRD equation at the end of 6 months and 1 yearTimepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Public ContactRaviteja Adapa
Sanofi India Limited
Outcome results
None listed